ReviewCurrent oncology reports2024

Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis.

Ricky Frazer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.